The US Food and Drug Administration (FDA) has authorised the first at-home PCR STI test for chlamydia, gonorrhoea, and ...

The U.S. Food and Drug Administration (FDA) has granted Visby Medical marketing authorization for its Women’s Sexual Health ...

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...

President Trump’s FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ...

and 98.5% of negative and 97.8% of positive Trichomonas vaginalis samples. The FDA cautioned that like other diagnostic tests, the main risk of the Visby product is the possibility of false ...

The FDA reviewed this test under the FDA’s De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk ...

The at-home kit, according to the FDA, is the first of its kind to test for chlamydia, gonorrhea and trichomoniasis, three of the most common STIs with symptoms that often go unnoticed.

UP Diliman biologists create an aptamer-based test for trichomoniasis detection, offering a potentially faster and more affordable alternative to current methods.